Suppr超能文献

体内大鼠肝脏中作为儿茶酚-O-甲基转移酶活性指标的甲氧基酪氨酸形成

Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.

作者信息

Kehr W, Zimmermann R, Thiede M

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):19-23. doi: 10.1007/BF00505075.

Abstract

The O-methyl derivative methoxytyrosine accumulated rapidly in rat liver after an intraperitoneal injection of L-dopa (50 mg/kg) in combination with 3-hydroxybenzylhydrazine, an inhibitor of the aromatic amino acid decarboxylase. Methoxytyrosine levels reached a plateau 40--60 min after i.p. injection of L-dopa, of which the tissue concentration declined monoexponentially. Injection of various doses of L-dopa revealed that methoxytyrosine formation was saturable and followed enzyme kinetics in rat liver. The catechol-O-methyltransferase inhibitors pyrogallol, tropolone and alpha-propyldopacetamide as well as the inhibitor of the aromatic amino acid decarboxylase benserazide inhibited the formation of methoxytyrosine dose-dependently and concomitantly increased the tissue concentration of dopa. The accumulation of methoxytyrosine from exogeneously applied L-dopa appears to be a reliable indicator of the in vivo activity of catechol-O-methyltransferase.

摘要

在腹腔注射左旋多巴(50毫克/千克)并联合芳香族氨基酸脱羧酶抑制剂3-羟基苄肼后,O-甲基衍生物甲氧基酪氨酸在大鼠肝脏中迅速蓄积。腹腔注射左旋多巴后40-60分钟,甲氧基酪氨酸水平达到平稳状态,之后其组织浓度呈单指数下降。注射不同剂量的左旋多巴表明,大鼠肝脏中甲氧基酪氨酸的形成具有饱和性并遵循酶动力学。儿茶酚-O-甲基转移酶抑制剂连苯三酚、托酚酮和α-丙基多巴酰胺以及芳香族氨基酸脱羧酶抑制剂苄丝肼均能剂量依赖性地抑制甲氧基酪氨酸的形成,并同时提高多巴的组织浓度。外源性给予左旋多巴后甲氧基酪氨酸的蓄积似乎是儿茶酚-O-甲基转移酶体内活性的可靠指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验